Objective-To assess the likely importance of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the arthritic process. Methods-Synovial samples from seven joints with rheumatoid arthritis and three osteoarthritic joints were analysed by indirect immunofluorescence microscopy. Using specific human antisera, we documented the frequencies and distributions of collagenase, stromelysins 1 and 2, matrilysin, gelatinases A and B, TIMP-1, and TIMP-2. 
that of MMPs. Conclusions-The presence of stromelysin 1 in all synovia clearly implicates this enzyme in joint damage. Collagenase, gelatinase A and matrilysin may also have a role in rheumatoid arthritis, but are not significant in osteoarthritis. However, marked regional variations were found in the synthesis of these MMPs, indicating not only that these diseases are episodic but that control of enzyme synthesis is focal. Only TIMP-1 may be considered an inhibitory factor.
(Ann Rheum Dis 1995; 54: [25] [26] [27] [28] [29] [30] [31] [32] Progressive degradation of the extracellular matrix of connective tissues and destruction of articular cartilage, intra-articular ligaments, tendons, and subchondral bone are major features of the arthritides, leading to disfigurement and permanent loss of function.' 2 Although proteinases of all mechanistic classes have the potential to degrade individual connective tissue macromolecules in vitro,3 the current view is that the initial step in matrix degradation is often an extracellular proteolytic process involving matrix metalloproteinases (MMPs). 4 MMPs are a family of metaldependent proteinases, which are active at neutral pH and secreted by mesenchymal and haemopoietic cells as proenzyme forms requiring extracellular activation. Their activities are further regulated by secreted inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). The MMP family can be divided into subgroups, three of which contain multiple gene products. The collagenases specifically cleave interstitial collagens types I, II, and III at a single locus; gelatinases (type IV collagenases) cleave denatured collagens and type IV collagen; while the stromelysins are more general proteinases, cleaving proteoglycan core protein, fibronectin and type IV collagen. In addition, a truncated MMP, matrilysin has a substrate specificity similar to that of the stromelysins. Together, these enzymes have the ability to degrade all the macromolecular components of connective tissues.
There is considerable evidence that connective tissues removed from patients with rheumatoid arthritis secrete greater concentrations of MMPs and their inhibitors into culture media than normal tissues.5`8 Cultures of adherent cells derived from rheumatoid synovia secreted collagenase into the culture media9 and collagenase was detected within such cellsl' and at sites of cartilage erosion in rheumatoid joints by immunolocalisation. " Stromelysin 112-15 and collagenase'6 have been demonstrated by immunolocalisation in lining cells of synovia and also mRNA for these proteins was detected by in situ hybridisation. '4 17-21 The last studies also identified collagenase and stromelysin mRNA in osteoarthritic synovium in smaller concentrations than in rheumatoid synovium. Primary rheumatoid synovial fibroblasts expressed high levels of stromelysin 1 Although the presence of collagenase, stromelysin and TIMP-1 have been well documented, other MMPs may also contribute to a predominance, either overall or focal, of proteinases over inhibitors, which could result in the breakdown of joint tissues in the arthritides. In this paper we have analysed synovia from seven joints with inflammatory arthritis and three osteoarthritic joints by indirect immunofluorescence microscopy to document the frequencies and distributions of six MMPs (collagenase, stromelysins 1 and 2, gelatinases A and B, matrilysin) and TIMP-1 and TIMP-2, in order to assess the likely importance of each in the arthritic process.
Materials and methods

TISSUES
Synovial samples were removed from 10 patients (table 1) . Seven of these patients had a diagnosis of rheumatoid arthritis, seropositive rheumatoid arthritis was present in five, and the other two were seronegative but otherwise satisfied the ARA criteria for rheumatoid arthritis. Three of the five patients with seropositive disease (patients 2, 3 and 4) were in an early proliferative phase of their disease showing only minimal damage to the articular cartilage, and were therefore managed by surgical synovectomy. The remaining two patients (1 and 5) had disease at a more advanced stage, with major destruction of both bone and articular cartilage leading to established secondary osteoarthritic changes. In these the surgical management was by joint debridement or arthroplasty and there was only minimal macroscopic evidence of increased vascularity and synovial hypertrophy. The two patients with atypical seronegative rheumatoid arthritis (patients 6 and 7) both showed advanced joint destruction, although this was still associated with marked proliferative synovial activity. The duration of the inflammatory arthritis varied from two to 24 years, but all patients had received prolonged drug treatment with non-steroidal antiinflammatory agents and some second-line therapy, such as sulphasalazine or gold salts. Only one patient (patient 6) with atypical seronegative arthritis had been taking systemic steroids for several months before removal of the synovial specimen. All joints in patients with rheumatoid arthritis had received one or more local steroid injections, with the exception of the elbow in patient 1 and the wrist in patient 7.
In the three patients with osteoarthritis, synovial specimens were removed at the time of surgery for replacement arthroplasty of the joint. In one of these (patient 8) there was macroscopic and microscopic evidence of a pyrophosphate arthropathy (pseudogout), with areas of stippled calcification in all the articular tissues in addition to marked synovial proliferation.
In the laboratory, small pieces were cut from each synovial sample and cultured for 6 h in Dulbecco's Modified Eagle's Medium with 10% fetal bovine serum and 5 pLmol/l monensin (Sigma) in an atmosphere of 5% carbon dioxide in air. They were then frozen in liquid nitrogen. A piece adjacent to each cultured sample was also taken and was frozen ex vivo.
ANTIBODIES
Specific polyclonal antibodies to human gelatinase A,25 pig gelatinase B (which cross reacts with human gelatinase B but not human gelatinase A29), human stromelysin (which reacts strongly with stromelysin 1 and weakly with stromelysin 23°), human TIMP-131 and TIMP-232 were raised in sheep. The characterisation of these antisera including species specificity, Western blots, inhibition curves Synovium from patient 6, the other subject with atypical seronegative rheumatoid arthritis, was also heavily infiltrated with inflammatory cells and, when stained with anti-stromelysin, showed strong immunofluorescence of extracellular matrix and cells (fig 2b) . As the antistromelysin antiserum reacts with both stromelysins 1 and 2 (see Methods), adjacent sections were stained with either the rabbit or the sheep antisera to stromelysin 2, and were found to be negative (fig 2c) , indicating that the matrix and cellular immunofluorescence were attributable to stromelysin 1. However, sections of this tissue stained with antimatrilysin contained discrete areas of lining cells with intracellular fluorescence (fig 2d) , indicating matrilysin synthesis. These areas frequently coincided with areas of bright stromelysin fluorescence. The distributions of collagenase, gelatinase A, and TIMP-1 were similar to those seen in patient 7, with TIMP-1 Figure 2 Immunolocalisation ofgelatinase, stromelysin and matrilysin in rheumatoid synovia. Synovia from patients 7 (a), and 6 (b, c, d) were cultured in monensin beforefreezing. Synovium from patient 2 (e, f) was frozen ex vivo. Tissues were sectioned and stained with anti-gelatinase (a, f), anti-stromelysin (b, e), sheep anti-stromelysin 2 indicating that the cells were synthesising stromelysin 1. Sections stained with the other antisera were negative, confirming the histological picture of a relatively inactive joint. Adjacent sections stained with NSS IgG as control were also negative. Ex vivo synovium from patient 5, which also showed more advanced disease with secondary osteoarthritic changes, contained a few polymorphonuclear leucocytes with intracellular gelatinase B immunofluorescence within small inflammatory cell foci. Polymorphonuclear leucocytes were identified in other ex vivo synovia using the methyl green nuclear counterstain and confirmed histologically, but they were negative for gelatinase B, presumably having degranulated before tissue excision.
As the synovial samples cultured in monensin from all patients had some stromelysin staining of extracellular matrix, samples frozen ex vivo without culture were also examined. Areas of positive matrix (but no positive cells) were again observed in samples from all patients. The synovium from patient 2 was highly villous with many lymphocytic foci and perivascular inflammation, bordered by a thickened lining layer: when frozen ex vivo, sectioned, and stained with antistromelysin IgG, sections had bright immunofluorescence of stromal matrix throughout (fig  2e) . Adjacent sections stained with NSS, anticollagenase, or anti-TIMP IgGs were negative, but sections stained with anti-gelatinase A had positive matrix in one limited area only (fig 2f) . These data indicate that stromelysin 1 and gelatinase A were bound to matrix in vivo, not as a result of the six hour period of culture with monensin. Sections from adjacent tissue cultured in monensin for six hours and stained with either NSS or anti-collagenase IgGs were negative, but sections stained with antistromelysin IgG had immunofluorescence both on collagenous matrix and within cells just below the lining layer, indicating stromelysin synthesis (not illustrated). Sections stained with anti-gelatinase A IgG had positive matrix only in one small region and a few positive cells (not illustrated). Anti-TIMP-1 stained sections also had a few positive stromal cells, and localised positive matrix mainly just below the lining layer in regions of cells with intracellular stromelysin (not illustrated).
As the immunofluorescence in the antistromelysin stained slides was so extensive and striking and does not occur in normal synovia (data not shown),18 20 the presence of stromelysin was cross checked by staining sections with an antiserum raised against active N-terminal stromelysin isolated from rabbit bone culture media; this antiserum cross reacts with human stromelysin.38 Both the antihuman and the anti-rabbit stromelysin antisera immunolocalise both active high molecular mass and latent prostromelysin on collagen fibrils. 30 The sections had both intracellular and matrix fluorescence, confirming the widespread distribution of stromelysin in this synovium. The experiments of Allan et al30 showed that this matrix bound enzyme could be either latent or active stromelysin, but also showed that TIMP-1 binds to matrix bound active stromelysin and not matrix bound prostromelysin. The immunolocalisation of TIMP-1 on matrix in the same region as stromelysin in this synovial sample suggests that at least a proportion of the stromelysin is in the active form. Sections stained with either the rabbit or sheep antisera to stromelysin 2 were negative, indicating that the matrix and cellular staining were attributable to stromelysin 1. Synovia from the three osteoarthritic joints (patients 8-10) were found to have a distribution of MMP similar to that in patient 1 with inactive rheumatoid arthritis (table 2).
All three had small areas of weak stromelysin 1 immunofluorescence on extracellular matrix in both ex vivo and cultured samples. The synovial lining cells were negative for collagenase in all samples, but one patient (patient 8) had a few lining cells positive for stromelysin.
Discussion
In this paper we have documented the frequencies and distributions of six MMPs and their natural inhibitors, TIMP-1 and TIMP-2, in seven rheumatoid and three osteoarthritic synovia. Stromelysin 1 was present in all synovia, in ex vivo tissue bound to extracellular matrix, within cells, or both, indicating stromelysin synthesis immediately following resection. The extent of staining varied both between samples and within each sample, but the most extensive matrix and cellular staining occurred in rheumatoid synovia. Stromelysin 2 was never observed, but intracellular matrilysin was seen in one active inflammatory synovium. Focal synthesis of collagenase was seen in lining cells of two synovia, and in connective tissue stromal cells in four synovia. Gelatinase A was observed in stromal cells from four synovia. TIMP-1 synthesis was observed in five synovia, and in two highly active synovia the distribution of TIMP-1 positive cells was more widespread than that of MMPs. No TIMP-2 was seen in any of the synovial samples.
To our knowledge this is the first report of the occurrence of stromelysin 1 bound to extracellular matrix components of synovia. It was present in ex vivo samples from both osteoarthritic and rheumatoid synovia, but was more widespread in the latter. Matrix staining was also identified in synovial samples which contained no stromelysin secreting cells (for example those from patient 3), suggesting that the stromelysin 1 may have been bound to the matrix for some time. Synthesis of stromelysin by synovial lining and stromal cells has been reported by other authors using both immunolocalisation2-`5 and in situ hybridisation methods'4 19 20 and our data reinforce their observations that expression is focal and related to the degree of inflammation. In situ methods would not, however, detect enzymes already bound to extracellular matrix. The polyclonal antiserum used in this study recognises both the pro, active and C-terminal forms of stromelysin30 and all these forms bind to collagen via the C-terminal domain.30 Stromelysin has a broad spectrum of activity against many components of the connective tissue matrix4 and its presence on the matrix over prolonged periods may contribute to potentiation of the synovitis.
None of the synovia examined contained any stromelysin 2 synovial biopsies and found that collagenase and TIMP-1 mRNA, although abundant in pre-steroid samples, were nearly undetectable in post-steroid-injection tissues.
The finding of stromelysin 1 in all synovial samples from 10 patients with disparate clinical diagnoses and histories, in contrast to its absence from normal synovia (data not shown), '8 20 clearly implicates this enzyme in the arthritic process. We have also shown that collagenase, gelatinase A, and matrilysin may have a role in the synovitis associated with rheumatoid arthritis, but are not a significant feature in osteoarthritic joints. However, marked regional variations were found in the synthesis of these MMPs, indicating that these diseases are episodic and that the control of enzyme synthesis is focal. This indicates the need for further work to colocalise MMP synthesis with cytokine expression in synovia from arthritic joints to explore the mechanisms which control the synthesis and degradation of extracellular matrix components in articular cartilage. A better understanding of the control of these processes may indicate ways to downregulate MMP overproduction without compromising normal tissue remodelling.
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